Labcorp Holdings INC 10-Q quarterly reports

Labcorp Holdings Inc. announced its first-quarter 2026 financial results, reporting a 5.8% increase in total revenues to $3,537.6 million, driven by organic growth and acquisitions.

Labcorp Holdings Inc. reported a significant increase in Q3 2025 revenues and net earnings, driven by robust organic growth and strategic acquisitions across its Diagnostics and Biopharma segments.

Labcorp Holdings Inc. announced a significant increase in revenues and net earnings for the second quarter and first half of 2025, fueled by strong organic growth and strategic acquisitions across its core laboratory services.

Labcorp's Q1 2025 revenue increased by 5.3% year-over-year, driven by acquisitions and organic growth, despite unfavorable foreign currency translation.

Labcorp Holdings Inc. announced a 7.4% increase in revenue for the third quarter of 2024, driven by acquisitions and growth in its base business, while also detailing its financial position and ongoing legal matters.

Labcorp Holdings Inc. announced a 6.2% increase in revenue for the second quarter of 2024, driven by strong growth in its base business and strategic acquisitions.

Labcorp's first quarter 2024 results show a 4.6% revenue increase year-over-year, fueled by growth in its base business and strategic acquisitions.